Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 619 | 10.61 |
09:34 ET | 685 | 10.57 |
09:36 ET | 2287 | 10.435 |
09:41 ET | 100 | 10.395 |
09:52 ET | 100 | 10.4 |
09:56 ET | 3503 | 10.41 |
09:57 ET | 2988 | 10.44 |
09:59 ET | 100 | 10.415 |
10:01 ET | 2910 | 10.5 |
10:03 ET | 600 | 10.5 |
10:06 ET | 400 | 10.46 |
10:08 ET | 100 | 10.5 |
10:10 ET | 100 | 10.495 |
10:12 ET | 11974 | 10.5 |
10:14 ET | 400 | 10.486 |
10:15 ET | 600 | 10.5 |
10:17 ET | 100 | 10.465 |
10:24 ET | 984 | 10.5 |
10:26 ET | 200 | 10.5 |
10:28 ET | 100 | 10.5 |
10:30 ET | 100 | 10.5 |
10:32 ET | 311 | 10.465 |
10:33 ET | 216 | 10.48 |
10:35 ET | 300 | 10.5 |
10:37 ET | 100 | 10.45 |
10:39 ET | 100 | 10.47 |
10:46 ET | 100 | 10.48 |
10:50 ET | 100 | 10.425 |
10:53 ET | 1467 | 10.5 |
10:55 ET | 525 | 10.48 |
10:57 ET | 3612 | 10.49 |
11:00 ET | 118 | 10.5 |
11:04 ET | 700 | 10.5 |
11:09 ET | 1900 | 10.5 |
11:11 ET | 100 | 10.5 |
11:13 ET | 900 | 10.5 |
11:15 ET | 200 | 10.5 |
11:18 ET | 300 | 10.5 |
11:20 ET | 200 | 10.5 |
11:22 ET | 1500 | 10.53 |
11:24 ET | 900 | 10.55 |
11:26 ET | 1394 | 10.505 |
11:27 ET | 1950 | 10.55 |
11:29 ET | 100 | 10.53 |
11:36 ET | 300 | 10.52 |
11:42 ET | 600 | 10.505 |
11:44 ET | 100 | 10.5 |
11:45 ET | 2100 | 10.55 |
11:47 ET | 135 | 10.49 |
11:58 ET | 2748 | 10.5 |
12:03 ET | 100 | 10.46 |
12:09 ET | 100 | 10.54 |
12:12 ET | 600 | 10.49 |
12:14 ET | 532 | 10.45 |
12:18 ET | 1490 | 10.42 |
12:20 ET | 100 | 10.51 |
12:23 ET | 100 | 10.51 |
12:25 ET | 500 | 10.455 |
12:34 ET | 100 | 10.51 |
12:38 ET | 100 | 10.51 |
12:45 ET | 2000 | 10.5 |
12:50 ET | 600 | 10.47 |
12:52 ET | 400 | 10.45 |
12:59 ET | 1697 | 10.4 |
01:06 ET | 4200 | 10.3 |
01:10 ET | 3701 | 10.2 |
01:12 ET | 592 | 10.22 |
01:14 ET | 720 | 10.25 |
01:17 ET | 923 | 10.38 |
01:24 ET | 500 | 10.37 |
01:28 ET | 300 | 10.35 |
01:33 ET | 183 | 10.33 |
01:35 ET | 1500 | 10.32 |
01:37 ET | 100 | 10.32 |
01:42 ET | 200 | 10.32 |
01:50 ET | 300 | 10.34 |
01:51 ET | 900 | 10.37 |
01:55 ET | 100 | 10.36 |
02:02 ET | 125 | 10.3622 |
02:08 ET | 4900 | 10.37 |
02:22 ET | 300 | 10.345 |
02:27 ET | 100 | 10.39 |
02:33 ET | 200 | 10.4 |
02:36 ET | 450 | 10.33 |
02:40 ET | 1554 | 10.3 |
02:47 ET | 300 | 10.23 |
02:49 ET | 2010 | 10.2118 |
03:00 ET | 200 | 10.26 |
03:02 ET | 100 | 10.26 |
03:03 ET | 700 | 10.19 |
03:05 ET | 475 | 10.1907 |
03:12 ET | 200 | 10.21 |
03:14 ET | 1299 | 10.19 |
03:18 ET | 100 | 10.195 |
03:21 ET | 100 | 10.21 |
03:25 ET | 200 | 10.21 |
03:27 ET | 600 | 10.18 |
03:32 ET | 100 | 10.18 |
03:34 ET | 950 | 10.06 |
03:38 ET | 1800 | 10.06 |
03:39 ET | 499 | 10.09 |
03:41 ET | 19464 | 10.04 |
03:43 ET | 700 | 10.03 |
03:45 ET | 400 | 10.1 |
03:48 ET | 6077 | 10 |
03:50 ET | 900 | 9.89 |
03:54 ET | 1336 | 9.91 |
03:56 ET | 2109 | 9.98 |
03:57 ET | 6005 | 10.04 |
03:59 ET | 5103 | 10.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 553.4M | -12.3x | --- |
Nano-X Imaging Ltd | 376.8M | -6.1x | --- |
Orchestra Biomed Holdings Inc | 245.2M | -4.7x | --- |
Cibus Inc | 229.1M | -0.5x | --- |
MaxCyte Inc | 427.6M | -11.6x | --- |
Vivos Inc | 88.9M | -25.6x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $553.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.74 |
EPS | $-0.82 |
Book Value | $0.80 |
P/E Ratio | -12.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.